Cleared Traditional

K081769 - INNOVANCE ANTITHROMBIN WITH MODELS OPFH03, OPFHO5 (FDA 510(k) Clearance)

May 2009
Decision
339d
Days
Class 2
Risk

K081769 is an FDA 510(k) clearance for the INNOVANCE ANTITHROMBIN WITH MODELS OPFH03, OPFHO5. This device is classified as a Antithrombin Iii Quantitation (Class II - Special Controls, product code JBQ).

Submitted by Siemens Healthcare Diagnostics (Newark, US). The FDA issued a Cleared decision on May 28, 2009, 339 days after receiving the submission on June 23, 2008.

This device falls under the Hematology FDA review panel. Regulated under 21 CFR 864.7060.

Submission Details

510(k) Number K081769 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 23, 2008
Decision Date May 28, 2009
Days to Decision 339 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Summary PDF

Device Classification

Product Code JBQ — Antithrombin Iii Quantitation
Device Class Class II - Special Controls
CFR Regulation 21 CFR 864.7060